BRUSSELS, BELGIUM / RankWire.AI / – In an effort to strengthen the fight against Ebola, the European Commission has announced the procurement of €2.1 million worth of PCR tests specifically for the Bundibugyo virus outbreak. This initiative involves open-platform testing kits that laboratories can integrate with their current systems. The procurement process received support from the European Health and Digital Executive Agency. Shipments are scheduled to commence in August, as health teams respond to a significant outbreak centered in the Democratic Republic of the Congo and impacting neighboring regions.
By August, the World Health Organization will facilitate the distribution of these tests through its Hub for Global Health Emergencies Logistics located in Dubai. WHO will oversee the distribution to various sites involved in the Ebola response. PCR testing enables laboratories to verify infections and enhance surveillance efforts around known cases. Confirmed test results inform patient treatment, isolation procedures, and contact tracing efforts. This latest supply package expands laboratory capabilities at a critical time when authorities continue to track the virus’s transmission across multiple provinces and health zones in the Democratic Republic of the Congo.
Earlier, the European Commission arranged another package valued at €2.5 million, which includes rapid molecular point-of-care tests and testing devices. These resources are intended to support the Africa Centres for Disease Control and Prevention’s regional response efforts. Combining both initiatives, the total diagnostic funding now reaches €4.6 million. These measures form part of broader European aid efforts aimed at tackling the Bundibugyo Ebola emergency. Support includes medical supplies, preparedness strategies, and public health resources designed to bolster response capabilities in affected and neighboring areas.
Testing Capacity Expands During Major Outbreak
As of August 12, WHO data reports that the Democratic Republic of the Congo has recorded 4,665 confirmed cases and 2,184 deaths. The outbreak spans across 54 health zones within six provinces, including Ituri, North Kivu, South Kivu, Haut-Uélé, Tshopo, and Bas-Uélé. WHO characterized this outbreak as the largest Ebola epidemic ever documented in the country. The organization also highlighted ongoing transmission within connected geographic clusters, which continues to place substantial pressure on surveillance teams, laboratories, treatment centers, and local health systems.
In its August update, WHO maintained a very high national risk assessment for the Democratic Republic of the Congo. It classified the regional risk for neighboring nations as high and indicated a low risk elsewhere. Following a meeting of its International Health Regulations Emergency Committee on August 24, WHO issued revised temporary guidelines. These include recommendations on surveillance, case detection, infection prevention, clinical management, and community engagement. The guidance also addresses mobility and mass gatherings during the ongoing response efforts.
European Health Support Reaches €493 Million
The European Commission has announced the mobilization of €493 million for emergency response measures, including vaccines, treatments, and health security initiatives across the Great Lakes region and Uganda. European health agencies also contribute to laboratory work, disease surveillance, and preparedness activities. The European Centre for Disease Prevention and Control continues to rate the risk posed to Europe as very low. Since Ebola primarily spreads through direct contact with infected bodily fluids, rapid detection, safe clinical practices, and effective infection control are essential to prevent transmission.
The Bundibugyo virus outbreak remains designated as a public health emergency of international concern under WHO’s framework. Currently, no approved vaccine or specific treatment exists for Bundibugyo virus disease. Consequently, health authorities rely heavily on surveillance, rapid diagnosis, patient isolation, clinical care, infection prevention, and close contact monitoring. The new PCR testing capacity further supports these efforts. WHO, Africa CDC, and national health authorities continue their coordinated operations to identify cases swiftly and maintain essential public health measures within affected communities.